Shinichiro Akizuki

Suggest Changes
Learn More
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) (lenograstim) was administered to healthy subjects at doses of 2, 5 and 10 μg/kg/day for 5 days (twice a day subcutaneously) to(More)